Sabra Health Care Stock Last Dividend Paid
| SBC Stock | EUR 17.88 0.05 0.28% |
Sabra Health Care fundamentals help investors to digest information that contributes to Sabra Health's financial success or failures. It also enables traders to predict the movement of Sabra Stock. The fundamental analysis module provides a way to measure Sabra Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sabra Health stock.
Sabra |
Sabra Health Care Company Last Dividend Paid Analysis
Sabra Health's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Current Sabra Health Last Dividend Paid | 1.2 |
Most of Sabra Health's fundamental indicators, such as Last Dividend Paid, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sabra Health Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Sabra Health Care has a Last Dividend Paid of 1.2. This is much higher than that of the Real Estate sector and significantly higher than that of the REIT - Healthcare Facilities industry. The last dividend paid for all Germany stocks is notably lower than that of the firm.
Sabra Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sabra Health's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sabra Health could also be used in its relative valuation, which is a method of valuing Sabra Health by comparing valuation metrics of similar companies.Sabra Health is rated second in last dividend paid category among its peers.
Sabra Fundamentals
| Return On Equity | -0.0241 | |||
| Return On Asset | 0.0155 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 5.1 B | |||
| Shares Outstanding | 231.16 M | |||
| Shares Owned By Insiders | 1.35 % | |||
| Shares Owned By Institutions | 90.40 % | |||
| Price To Earning | 25.24 X | |||
| Price To Book | 0.90 X | |||
| Price To Sales | 6.70 X | |||
| Revenue | 624.81 M | |||
| Gross Profit | 372.8 M | |||
| EBITDA | 216.89 M | |||
| Net Income | (77.61 M) | |||
| Cash And Equivalents | 56.81 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 2.31 B | |||
| Debt To Equity | 106.60 % | |||
| Current Ratio | 5.91 X | |||
| Book Value Per Share | 13.23 X | |||
| Cash Flow From Operations | 315.73 M | |||
| Earnings Per Share | (0.33) X | |||
| Target Price | 19.14 | |||
| Number Of Employees | 42 | |||
| Beta | 1.29 | |||
| Market Capitalization | 2.59 B | |||
| Total Asset | 5.75 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.09 % | |||
| Net Asset | 5.75 B | |||
| Last Dividend Paid | 1.2 |
About Sabra Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sabra Health Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sabra Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sabra Health Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Sabra Stock
Sabra Health financial ratios help investors to determine whether Sabra Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sabra with respect to the benefits of owning Sabra Health security.